Some physicians actually prefer that their patients remain on bupropion during tirzepatide treatment because the dopaminergic support helps maintain motivation and prevents the emotional eating rebound that can sabotage weight loss efforts

Clinical Application Comparison# When Alprostadil Is the Clear Choice# Organic ED with identified vascular or neurogenic cause alprostadil's mechanical mechanism works regardless of etiology PDE5 inhibitor failure alprostadil is the established second-line therapy Post-prostatectomy ED nerve-independent mechanism is particularly valuable when cavernosal nerves have been damaged Diabetes-related ED high efficacy in diabetic ED where vascular and neurological pathology coexist Need for reliable, predictable erection alprostadil's direct mechanism produces erection more reliably than any centrally-acting agent When PT-141 May Be Relevant# Hypoactive sexual desire disorder PT-141's approved indication, targeting the desire deficit rather than erectile mechanics Psychogenic sexual dysfunction central mechanism may address brain-level arousal and desire issues Patients who decline penile injection subcutaneous autoinjection is less invasive than intracavernosal injection Combined desire and arousal dysfunction PT-141 may complement (not replace) peripheral ED treatments by addressing the desire component Can They Be Combined?# Combining alprostadil and PT-141 is theoretically logical since they act at completely different levels peripheral mechanics (alprostadil) and central desire (PT-141)

Fiber is another nutrient that can help support weight loss by promoting feelings of fullness and reducing calorie intake
Junger S, Payne SA, Brine J, Radbruch L, Brearley SG
Can you come to my hotel, yacht, office, or event